Guidance Capital’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-24,791
Closed -$594K 263
2025
Q4
$594K Buy
24,791
+364
+1% +$8.86K 0.15% 145
2025
Q3
$635K Buy
24,427
+993
+4% +$21.4K 0.17% 134
2025
Q2
$442K Buy
23,434
+361
+2% +$8.36K 0.13% 154
2025
Q1
$538K Buy
23,073
+251
+1% +$5.83K 0.16% 123
2024
Q4
$515K Sell
22,822
-2,841
-11% -$56.3K 0.16% 120
2024
Q3
$458K Buy
25,663
+1,835
+8% +$35K 0.14% 146
2024
Q2
$494K Buy
23,828
+2,703
+13% +$47.9K 0.16% 135
2024
Q1
$388K Buy
+21,125
New +$446K 0.14% 143

Other funds holding PRVA

Guidance Capital's PRVA Position: Q1 2026 in Review

Guidance Capital sold out of Privia Health (PRVA) in Q1 2026, closing a stake of 24,791 shares — an estimated $594K sold.

Guidance Capital first reported a position in PRVA in Q1 2024 and held it in 8 quarters. The position peaked at $635K in Q3 2025. 293 funds tracked by Wall St. Rank hold PRVA as of Q1 2026.

  • Guidance Capital reported no remaining Privia Health position as of Q1 2026 after selling out during the quarter.
  • Guidance Capital sold 24,791 Privia Health shares in Q1 2026, an estimated $594K.
  • Guidance Capital first reported a position in Privia Health in Q1 2024 and held it in 8 quarters.
  • Guidance Capital's Privia Health position peaked at $635K in Q3 2025.
  • 293 funds tracked by Wall St. Rank held Privia Health as of Q1 2026.

Based on Guidance Capital's 13F filing for Q1 2026, filed 8 May 2026.